正常血钙型原发性甲状旁腺功能亢进术后骨结构变化
前瞻性研究纳入2016至2018年87例原发性甲状旁腺功能亢进手术患者,比较正常血钙型与高血钙型术后1年和2年骨密度与骨转换标志物变化。术后1年腰椎和股骨颈骨密度升高,桡骨远端三分之一无变化,两组间无显著差异。骨转换标志物术后1年显著下降。作者认为术后第一年改善最明显,但需更长随访研究。
要点
- 术后1年腰椎骨密度平均升高0.029 g/cm2,股骨颈平均升高0.025 g/cm2,桡骨远端三分之一无变化。
- 正常血钙型与高血钙型原发性甲状旁腺功能亢进术后骨密度变化无显著差异。
- 术后1年P1NP、骨钙素和BCTX均较术前显著下降。
核心结论
- 甲状旁腺切除术对正常血钙型和高血钙型原发性甲状旁腺功能亢进在骨改善方面具有相似益处。
- 两组术后第一年骨改善最显著,但作者认为需更长随访研究。
研究设计与样本
- 前瞻性研究纳入2016至2018年连续87例诊断为原发性甲状旁腺功能亢进并接受手术的患者。
- 术前及术后进行骨密度测定(桡骨远端三分之一、腰椎、股骨)和骨转换标志物(骨钙素、1型前胶原氨基端前肽[P1NP]、1型胶原β-交联端肽[BCTX])检测。
- 根据临床特征和个体生化特征比较和评估术后骨密度及骨标志物变化。
主要发现
- 术后1年所有患者腰椎骨密度平均升高0.029 g/cm2(范围0.017-0.04,P < .001),股骨颈平均升高0.025 g/cm2(范围0.002-0.05,P < .001),桡骨远端三分之一无变化(平均-0.003 g/cm2,范围-0.008至0.002,P = NS)。
- 正常血钙型原发性甲状旁腺功能亢进与高血钙型原发性甲状旁腺功能亢进比较无显著差异。
- 术前血清骨钙素(37 ± 17.41)、P1NP(67.53 ± 31.81)和BCTX(0.64 ± 0.37)水平升高。
- 术后1年P1NP显著下降至33.05 ± 13.16(P = .001),骨钙素显著下降至15.80 ± 6.19(P = .001),BCTX显著下降至0.26 ± 0.32(P < .001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需更长随访研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bone disease in primary hyperparathyroidism is a clear indication for surgical treatment. However, it is not known whether surgery benefits hypercalcemic primary hyperparathyroidism and normocalcemic primary hyperparathyroidism equally. The aim of our study was to evaluate the bone changes in patients undergoing parathyroidectomy based on the biochemical profile 1 and 2 years after surgery. METHODS: This prospective study included 87 consecutive patients diagnosed with primary hyperparathyroidism who underwent surgery between 2016 and 2018. Bone densitometry (1/3 distal radius, lumbar, and femur) and bone remodeling markers (osteocalcin, type 1 procollagen [P1NP], β-cross-linked telopeptide of type I collagen [BCTX]) were performed preoperatively and postoperatively. Postoperative changes in bone mineral density and bone markers were compared and evaluated according to the clinical characteristics and the individual biochemical profile. RESULTS: One year after surgery, all patients showed an increase in bone mineral density at the lumbar site (mean, 0.029 g/cm2; range, 0.017-0.04; P < .001) and femur neck (mean, 0.025 g/cm2; range, 0.002-0.05; P < .001); however, there were no changes in the distal third of the radius (mean, -0.003 g/cm2; range, -0.008 to 0.002; P = NS). There were no significant differences when comparing normocalcemic primary hyperparathyroidism and hypercalcemic primary hyperparathyroidism. Serum osteocalcin (37 ± 17.41), P1NP (67.53 ± 31.81) and BCTX (0.64 ± 0.37) levels were elevated before surgery. One year after the surgery, we observed a significant decrease in P1NP (33.05 ± 13.16, P = .001), osteocalcin (15.80 ± 6.19, P = .001), and BCTX (0.26 ± 0.32, P < .001) levels. CONCLUSION: Our findings indicate that parathyroidectomy has similar benefits for normocalcemic primary hyperparathyroidism and hypercalcemic primary hyperparathyroidism in terms of bone improvement. Although the most substantial improvement occurred during the first postoperative year in both groups, we consider that studies with longer follow-up are warranted.
引用
- Osorio-Silla I, Gómez-Ramírez J, Valdazo-Gómez A, et al. What happens to the bone structure after normocalcemic primary hyperparathyroidism surgery? Surgery. 2021. PMID: 34736792. doi:10.1016/j.surg.2021.08.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。